Table of Content

1. Global Market - Executive Summary
 1.1. Global Market Overview
 1.2. Demand Side Trends
 1.3. Supply Side Trends
 1.4. Fact.MR Analysis and Recommendations
2. Global Market Overview
 2.1. Market Coverage / Taxonomy
 2.2. Market Introduction and Definition
3. Key Market Trends
 3.1. Key Trends Impacting the Market
4. Key Success Factors
 4.1. Epidemiology of Polyneuropathy
 4.2. Pharmacotherapy for Neuropathic Pain
 4.3. Pipeline Assessment by Manufacturer
5. Market Background
 5.1. Value Added Insights
  5.1.1. Regulatory Landscape, By Country
  5.1.2. Reimbursement Scenario
  5.1.3. Supply Chain Analysis
  5.1.4. Porter’s Analysis
  5.1.5. PESTLE Analysis, By Region
 5.2. Macro-Economic Factors
  5.2.1. Global Healthcare Expenditure Market Outlook
  5.2.2. Global R&D funding By Region & Country
  5.2.3. Parent Market Analysis
 5.3. Forecast Factors - Relevance & Impact
  5.3.1. Incidence of Peripheral Neuropathy
  5.3.2. Growing Awareness of Polyneuropathy
  5.3.3. Advancements in Treatment Options
  5.3.4. Increasing R&D Investments
  5.3.5. Healthcare Infrastructure Expansion
  5.3.6. Rising Aging Population
 5.4. Market Dynamics
  5.4.1. Drivers
  5.4.2. Restraints
  5.4.3. Opportunity Analysis
6. Global Market Demand (US$ Mn) Analysis 2019-2023 and Forecast, 2024-2034
 6.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
 6.2. Current and Future Market Value (US$ Mn) Projections, 2024-2034
  6.2.1. Y-o-Y Growth Trend Analysis
  6.2.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2019-2023 and Forecast 2024-2034, By Type
 7.1. Introduction / Key Findings
 7.2. Historical Market Value (US$ Mn) Analysis By Type, 2019-2023
 7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Type, 2024-2034
  7.3.1. Diabetic Polyneuropathy
  7.3.2. Chemotherapy-induced Polyneuropathy
  7.3.3. Idiopathic Polyneuropathy
  7.3.4. HIV/AIDS associated Polyneuropathy
  7.3.5. Autoimmune Polyneuropathy
 7.4. Market Attractiveness Analysis By Type
8. Global Market Analysis 2019-2023 and Forecast 2024-2034, By Treatment
 8.1. Introduction / Key Findings
 8.2. Historical Market Value (US$ Mn) Analysis By Treatment, 2019-2023
 8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Treatment, 2024-2034
  8.3.1. Drugs (Analgesics, Antidepressants, Anticonvulsants/Antiepileptics, Other Drugs)
  8.3.2. Other Treatments (Transcutaneous Electrical Nerve Stimulation, Plasma Exchange)
 8.4. Market Attractiveness Analysis By Treatment
9. Global Market Analysis 2019-2023 and Forecast 2024-2034, By Distribution Channel
 9.1. Introduction / Key Findings
 9.2. Historical Market Value (US$ Mn) Analysis By Distribution Channel, 2019-2023
 9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2024-2034
  9.3.1. Hospitals
  9.3.2. Clinics
  9.3.3. Retail Pharmacies
  9.3.4. Online Pharmacies
 9.4. Market Attractiveness Analysis By Distribution Channel
10. Global Market Analysis 2019-2023 and Forecast 2024 to 2034, By Region
 10.1. Introduction / Key Findings
 10.2. Historical Market Value (US$ Mn) Analysis By Region, 2019-2023
 10.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024-2034
  10.3.1. North America
  10.3.2. Latin America
  10.3.3. East Asia
  10.3.4. South Asia & Pacific
  10.3.5. Western Europe
  10.3.6. Eastern Europe
  10.3.7. Middle East and Africa (MEA)
 10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2019-2023 and Forecast 2024-2034
 11.1. Introduction / Key Findings
 11.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
 11.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2024-2034
  11.3.1. By Country
   11.3.1.1. United States
   11.3.1.2. Canada
  11.3.2. By Type
  11.3.3. By Treatment
 11.4. Market Attractiveness Analysis
  11.4.1. By Country
  11.4.2. By Type
  11.4.3. By Treatment
12. Latin America Market Analysis 2019-2023 and Forecast 2024-2034
 12.1. Introduction / Key Findings
 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024-2034
  12.3.1. By Country
   12.3.1.1. Brazil
   12.3.1.2. Mexico
   12.3.1.3. Rest of Latin America
  12.3.2. By Type
  12.3.3. By Treatment
  12.3.4. By Distribution Channel
 12.4. Market Attractiveness Analysis
  12.4.1. By Country
  12.4.2. By Type
  12.4.3. By Treatment
  12.4.4. By Distribution Channel
13. East Asia Market Analysis 2019-2023 and Forecast 2024-2034
 13.1. Introduction / Key Findings
 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024-2034
  13.3.1. By Country
   13.3.1.1. China
   13.3.1.2. Japan
   13.3.1.3. South Korea
  13.3.2. By Type
  13.3.3. By Treatment
  13.3.4. By Distribution Channel
 13.4. Market Attractiveness Analysis
  13.4.1. By Country
  13.4.2. By Type
  13.4.3. By Treatment
  13.4.4. By Distribution Channel
14. South Asia & Pacific Market Analysis 2019-2023 and Forecast 2024-2034
 14.1. Introduction / Key Findings
 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024-2034
  14.3.1. By Country
   14.3.1.1. India
   14.3.1.2. ASEAN
   14.3.1.3. Australia & New Zealand
   14.3.1.4. Rest of South Asia
  14.3.2. By Type
  14.3.3. By Treatment
  14.3.4. By Distribution Channel
 14.4. Market Attractiveness Analysis
  14.4.1. By Country
  14.4.2. By Type
  14.4.3. By Treatment
  14.4.4. By Distribution Channel
15. Western Europe Market Analysis 2019-2023 and Forecast 2024-2034
 15.1. Introduction / Key Findings
 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024-2034
  15.3.1. By Country
   15.3.1.1. Germany
   15.3.1.2. Italy
   15.3.1.3. France
   15.3.1.4. U.K.
   15.3.1.5. Spain
   15.3.1.6. BENELUX
   15.3.1.7. Nordic Countries
   15.3.1.8. Rest of Western Europe
  15.3.2. By Type
  15.3.3. By Treatment
  15.3.4. By Distribution Channel
 15.4. Market Attractiveness Analysis
  15.4.1. By Country
  15.4.2. By Type
  15.4.3. By Treatment
  15.4.4. By Distribution Channel
16. Eastern Europe Market Analysis 2019-2023 and Forecast 2024-2034
 16.1. Introduction / Key Findings
 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
 16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024-2034
  16.3.1. By Country
   16.3.1.1. Russia
   16.3.1.2. Hungary
   16.3.1.3. Poland
   16.3.1.4. Balkan & Baltic Countries
   16.3.1.5. Rest of Eastern Europe
  16.3.2. By Type
  16.3.3. By Treatment
  16.3.4. By Distribution Channel
 16.4. Market Attractiveness Analysis
  16.4.1. By Country
  16.4.2. By Type
  16.4.3. By Treatment
  16.4.4. By Distribution Channel
17. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2034
 17.1. Introduction / Key Findings
 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
 17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024-2034
  17.3.1. By Country
   17.3.1.1. Kingdom of Saudi Arabia
   17.3.1.2. Other GCC Countries
   17.3.1.3. Turkiye
   17.3.1.4. South Africa
   17.3.1.5. Rest of MEA
  17.3.2. By Type
  17.3.3. By Treatment
  17.3.4. By Distribution Channel
 17.4. Market Attractiveness Analysis
  17.4.1. By Country
  17.4.2. By Type
  17.4.3. By Treatment
  17.4.4. By Distribution Channel
18. Market Structure Analysis
 18.1. Market Analysis by Tier of Companies
 18.2. Market Concentration
 18.3. Market Share Analysis of Top Players
 18.4. Market Presence Analysis
19. Competition Analysis
 19.1. Competition Dashboard
 19.2. Competition Benchmarking
 19.3. Branding & Promotional Strategies
 19.4. Key Development Analysis
 19.5. Competition Deep Dive
  19.5.1. Pfizer Inc.
   19.5.1.1. Company Overview
   19.5.1.2. Region Portfolio
   19.5.1.3. Key Financial
   19.5.1.4. Sales Footprint
   19.5.1.5. SWOT Analysis
   19.5.1.6. Key Developments
   19.5.1.7. Strategy Overview
  19.5.2. Abbott Laboratories
   19.5.2.1. Company Overview
   19.5.2.2. Region Portfolio
   19.5.2.3. Key Financial
   19.5.2.4. Sales Footprint
   19.5.2.5. SWOT Analysis
   19.5.2.6. Key Developments
   19.5.2.7. Strategy Overview
  19.5.3. Johnson & Johnson (Janssen Global Services LLC)
   19.5.3.1. Company Overview
   19.5.3.2. Region Portfolio
   19.5.3.3. Key Financial
   19.5.3.4. Sales Footprint
   19.5.3.5. SWOT Analysis
   19.5.3.6. Key Developments
   19.5.3.7. Strategy Overview
  19.5.4. Lupin Limited
   19.5.4.1. Company Overview
   19.5.4.2. Region Portfolio
   19.5.4.3. Key Financial
   19.5.4.4. Sales Footprint
   19.5.4.5. SWOT Analysis
   19.5.4.6. Key Developments
   19.5.4.7. Strategy Overview
  19.5.5. Eli Lilly & Co.
   19.5.5.1. Company Overview
   19.5.5.2. Region Portfolio
   19.5.5.3. Key Financial
   19.5.5.4. Sales Footprint
   19.5.5.5. SWOT Analysis
   19.5.5.6. Key Developments
   19.5.5.7. Strategy Overview
  19.5.6. Glenmark Pharmaceuticals Ltd.
   19.5.6.1. Company Overview
   19.5.6.2. Region Portfolio
   19.5.6.3. Key Financial
   19.5.6.4. Sales Footprint
   19.5.6.5. SWOT Analysis
   19.5.6.6. Key Developments
   19.5.6.7. Strategy Overview
  19.5.7. Teva Pharmaceuticals
   19.5.7.1. Company Overview
   19.5.7.2. Region Portfolio
   19.5.7.3. Key Financial
   19.5.7.4. Sales Footprint
   19.5.7.5. SWOT Analysis
   19.5.7.6. Key Developments
   19.5.7.7. Strategy Overview
  19.5.8. Medtronic
   19.5.8.1. Company Overview
   19.5.8.2. Region Portfolio
   19.5.8.3. Key Financial
   19.5.8.4. Sales Footprint
   19.5.8.5. SWOT Analysis
   19.5.8.6. Key Developments
   19.5.8.7. Strategy Overview
  19.5.9. AbbVie
   19.5.9.1. Company Overview
   19.5.9.2. Region Portfolio
   19.5.9.3. Key Financial
   19.5.9.4. Sales Footprint
   19.5.9.5. SWOT Analysis
   19.5.9.6. Key Developments
   19.5.9.7. Strategy Overview
  19.5.10. Zydus Healthcare Ltd.
   19.5.10.1. Company Overview
   19.5.10.2. Region Portfolio
   19.5.10.3. Key Financial
   19.5.10.4. Sales Footprint
   19.5.10.5. SWOT Analysis
   19.5.10.6. Key Developments
   19.5.10.7. Strategy Overview
  19.5.11. Astellas Pharma Inc.
   19.5.11.1. Company Overview
   19.5.11.2. Region Portfolio
   19.5.11.3. Key Financial
   19.5.11.4. Sales Footprint
   19.5.11.5. SWOT Analysis
   19.5.11.6. Key Developments
   19.5.11.7. Strategy Overview
  19.5.12. Depomed Inc.
   19.5.12.1. Company Overview
   19.5.12.2. Region Portfolio
   19.5.12.3. Key Financial
   19.5.12.4. Sales Footprint
   19.5.12.5. SWOT Analysis
   19.5.12.6. Key Developments
   19.5.12.7. Strategy Overview
  19.5.13. Helixmith Co Ltd.
   19.5.13.1. Company Overview
   19.5.13.2. Region Portfolio
   19.5.13.3. Key Financial
   19.5.13.4. Sales Footprint
   19.5.13.5. SWOT Analysis
   19.5.13.6. Key Developments
   19.5.13.7. Strategy Overview
  19.5.14. OMRON Healthcare, Inc.
   19.5.14.1. Company Overview
   19.5.14.2. Region Portfolio
   19.5.14.3. Key Financial
   19.5.14.4. Sales Footprint
   19.5.14.5. SWOT Analysis
   19.5.14.6. Key Developments
   19.5.14.7. Strategy Overview
  19.5.15. Viatris Inc.
   19.5.15.1. Company Overview
   19.5.15.2. Region Portfolio
   19.5.15.3. Key Financial
   19.5.15.4. Sales Footprint
   19.5.15.5. SWOT Analysis
   19.5.15.6. Key Developments
   19.5.15.7. Strategy Overview
  19.5.16. Nevro Corp.
   19.5.16.1. Company Overview
   19.5.16.2. Region Portfolio
   19.5.16.3. Key Financial
   19.5.16.4. Sales Footprint
   19.5.16.5. SWOT Analysis
   19.5.16.6. Key Developments
   19.5.16.7. Strategy Overview
  19.5.17. Dr. Reddy?s Laboratories Ltd.
   19.5.17.1. Company Overview
   19.5.17.2. Region Portfolio
   19.5.17.3. Key Financial
   19.5.17.4. Sales Footprint
   19.5.17.5. SWOT Analysis
   19.5.17.6. Key Developments
   19.5.17.7. Strategy Overview
  19.5.18. Gr?nenthal Group
   19.5.18.1. Company Overview
   19.5.18.2. Region Portfolio
   19.5.18.3. Key Financial
   19.5.18.4. Sales Footprint
   19.5.18.5. SWOT Analysis
   19.5.18.6. Key Developments
   19.5.18.7. Strategy Overview
20. Assumptions and Acronyms Used
21. Research Methodology



List of Figures

Figure 01: Global Market Value (US$ Mn) by Treatment, 2024-2034

Figure 02: Global Market Value (US$ Mn) by Type, 2024-2034

Figure 03: Global Market Value (US$ Mn) by Distribution Channel, 2024-2034

Figure 04: Global Market Value (US$ Mn) by Region, 2024-2034

Figure 05: Global Market Value (US$ Mn) Analysis by Region, 2019-2034

Figure 06: Global Market Value Share (%) Analysis by Region, 2024-2034

Figure 07: Global Market Y-o-Y Growth (%) Projections by Region, 2024-2034

Figure 08: Global Market Value (US$ Mn) Analysis by Treatment, 2019-2034

Figure 09: Global Market Value Share (%) Analysis by Treatment, 2024-2034

Figure 10: Global Market Y-o-Y Growth (%) Projections by Treatment, 2024-2034

Figure 11: Global Market Value (US$ Mn) Analysis by Type, 2019-2034

Figure 12: Global Market Value Share (%) Analysis by Type, 2024-2034

Figure 13: Global Market Y-o-Y Growth (%) Projections by Type, 2024-2034

Figure 14: Global Market Value (US$ Mn) Analysis by Distribution Channel, 2019-2034

Figure 15: Global Market Value Share (%) Analysis by Distribution Channel, 2024-2034

Figure 16: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024-2034

Figure 17: Global Market Attractiveness by Treatment, 2024-2034

Figure 18: Global Market Attractiveness by Type, 2024-2034

Figure 19: Global Market Attractiveness by Distribution Channel, 2024-2034

Figure 20: Global Market Attractiveness by Region, 2024-2034

Figure 21: North America Market Value (US$ Mn) by Treatment, 2024-2034

Figure 22: North America Market Value (US$ Mn) by Type, 2024-2034

Figure 23: North America Market Value (US$ Mn) by Distribution Channel, 2024-2034

Figure 24: North America Market Value (US$ Mn) by Country, 2024-2034

Figure 25: North America Market Value (US$ Mn) Analysis by Country, 2019-2034

Figure 26: North America Market Value Share (%) Analysis by Country, 2024-2034

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2024-2034

Figure 28: North America Market Value (US$ Mn) Analysis by Treatment, 2019-2034

Figure 29: North America Market Value Share (%) Analysis by Treatment, 2024-2034

Figure 30: North America Market Y-o-Y Growth (%) Projections by Treatment, 2024-2034

Figure 31: North America Market Value (US$ Mn) Analysis by Type, 2019-2034

Figure 32: North America Market Value Share (%) Analysis by Type, 2024-2034

Figure 33: North America Market Y-o-Y Growth (%) Projections by Type, 2024-2034

Figure 34: North America Market Value (US$ Mn) Analysis by Distribution Channel, 2019-2034

Figure 35: North America Market Value Share (%) Analysis by Distribution Channel, 2024-2034

Figure 36: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024-2034

Figure 37: North America Market Attractiveness by Treatment, 2024-2034

Figure 38: North America Market Attractiveness by Type, 2024-2034

Figure 39: North America Market Attractiveness by Distribution Channel, 2024-2034

Figure 40: North America Market Attractiveness by Country, 2024-2034

Figure 41: Latin America Market Value (US$ Mn) by Treatment, 2024-2034

Figure 42: Latin America Market Value (US$ Mn) by Type, 2024-2034

Figure 43: Latin America Market Value (US$ Mn) by Distribution Channel, 2024-2034

Figure 44: Latin America Market Value (US$ Mn) by Country, 2024-2034

Figure 45: Latin America Market Value (US$ Mn) Analysis by Country, 2019-2034

Figure 46: Latin America Market Value Share (%) Analysis by Country, 2024-2034

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024-2034

Figure 48: Latin America Market Value (US$ Mn) Analysis by Treatment, 2019-2034

Figure 49: Latin America Market Value Share (%) Analysis by Treatment, 2024-2034

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Treatment, 2024-2034

Figure 51: Latin America Market Value (US$ Mn) Analysis by Type, 2019-2034

Figure 52: Latin America Market Value Share (%) Analysis by Type, 2024-2034

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Type, 2024-2034

Figure 54: Latin America Market Value (US$ Mn) Analysis by Distribution Channel, 2019-2034

Figure 55: Latin America Market Value Share (%) Analysis by Distribution Channel, 2024-2034

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024-2034

Figure 57: Latin America Market Attractiveness by Treatment, 2024-2034

Figure 58: Latin America Market Attractiveness by Type, 2024-2034

Figure 59: Latin America Market Attractiveness by Distribution Channel, 2024-2034

Figure 60: Latin America Market Attractiveness by Country, 2024-2034

Figure 61: East Asia Market Value (US$ Mn) by Treatment, 2024-2034

Figure 62: East Asia Market Value (US$ Mn) by Type, 2024-2034

Figure 63: East Asia Market Value (US$ Mn) by Distribution Channel, 2024-2034

Figure 64: East Asia Market Value (US$ Mn) by Country, 2024-2034

Figure 65: East Asia Market Value (US$ Mn) Analysis by Country, 2019-2034

Figure 66: East Asia Market Value Share (%) Analysis by Country, 2024-2034

Figure 67: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024-2034

Figure 68: East Asia Market Value (US$ Mn) Analysis by Treatment, 2019-2034

Figure 69: East Asia Market Value Share (%) Analysis by Treatment, 2024-2034

Figure 70: East Asia Market Y-o-Y Growth (%) Projections by Treatment, 2024-2034

Figure 71: East Asia Market Value (US$ Mn) Analysis by Type, 2019-2034

Figure 72: East Asia Market Value Share (%) Analysis by Type, 2024-2034

Figure 73: East Asia Market Y-o-Y Growth (%) Projections by Type, 2024-2034

Figure 74: East Asia Market Value (US$ Mn) Analysis by Distribution Channel, 2019-2034

Figure 75: East Asia Market Value Share (%) Analysis by Distribution Channel, 2024-2034

Figure 76: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024-2034

Figure 77: East Asia Market Attractiveness by Treatment, 2024-2034

Figure 78: East Asia Market Attractiveness by Type, 2024-2034

Figure 79: East Asia Market Attractiveness by Distribution Channel, 2024-2034

Figure 80: East Asia Market Attractiveness by Country, 2024-2034

Figure 81: South Asia & Pacific Market Value (US$ Mn) by Treatment, 2024-2034

Figure 82: South Asia & Pacific Market Value (US$ Mn) by Type, 2024-2034

Figure 83: South Asia & Pacific Market Value (US$ Mn) by Distribution Channel, 2024-2034

Figure 84: South Asia & Pacific Market Value (US$ Mn) by Country, 2024-2034

Figure 85: South Asia & Pacific Market Value (US$ Mn) Analysis by Country, 2019-2034

Figure 86: South Asia & Pacific Market Value Share (%) Analysis by Country, 2024-2034

Figure 87: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Country, 2024-2034

Figure 88: South Asia & Pacific Market Value (US$ Mn) Analysis by Treatment, 2019-2034

Figure 89: South Asia & Pacific Market Value Share (%) Analysis by Treatment, 2024-2034

Figure 90: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Treatment, 2024-2034

Figure 91: South Asia & Pacific Market Value (US$ Mn) Analysis by Type, 2019-2034

Figure 92: South Asia & Pacific Market Value Share (%) Analysis by Type, 2024-2034

Figure 93: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Type, 2024-2034

Figure 94: South Asia & Pacific Market Value (US$ Mn) Analysis by Distribution Channel, 2019-2034

Figure 95: South Asia & Pacific Market Value Share (%) Analysis by Distribution Channel, 2024-2034

Figure 96: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024-2034

Figure 97: South Asia & Pacific Market Attractiveness by Treatment, 2024-2034

Figure 98: South Asia & Pacific Market Attractiveness by Type, 2024-2034

Figure 99: South Asia & Pacific Market Attractiveness by Distribution Channel, 2024-2034

Figure 100: South Asia & Pacific Market Attractiveness by Country, 2024-2034

Figure 101: Western Europe Market Value (US$ Mn) by Treatment, 2024-2034

Figure 102: Western Europe Market Value (US$ Mn) by Type, 2024-2034

Figure 103: Western Europe Market Value (US$ Mn) by Distribution Channel, 2024-2034

Figure 104: Western Europe Market Value (US$ Mn) by Country, 2024-2034

Figure 105: Western Europe Market Value (US$ Mn) Analysis by Country, 2019-2034

Figure 106: Western Europe Market Value Share (%) Analysis by Country, 2024-2034

Figure 107: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024-2034

Figure 108: Western Europe Market Value (US$ Mn) Analysis by Treatment, 2019-2034

Figure 109: Western Europe Market Value Share (%) Analysis by Treatment, 2024-2034

Figure 110: Western Europe Market Y-o-Y Growth (%) Projections by Treatment, 2024-2034

Figure 111: Western Europe Market Value (US$ Mn) Analysis by Type, 2019-2034

Figure 112: Western Europe Market Value Share (%) Analysis by Type, 2024-2034

Figure 113: Western Europe Market Y-o-Y Growth (%) Projections by Type, 2024-2034

Figure 114: Western Europe Market Value (US$ Mn) Analysis by Distribution Channel, 2019-2034

Figure 115: Western Europe Market Value Share (%) Analysis by Distribution Channel, 2024-2034

Figure 116: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024-2034

Figure 117: Western Europe Market Attractiveness by Treatment, 2024-2034

Figure 118: Western Europe Market Attractiveness by Type, 2024-2034

Figure 119: Western Europe Market Attractiveness by Distribution Channel, 2024-2034

Figure 120: Western Europe Market Attractiveness by Country, 2024-2034

Figure 121: Eastern Europe Market Value (US$ Mn) by Treatment, 2024-2034

Figure 122: Eastern Europe Market Value (US$ Mn) by Type, 2024-2034

Figure 123: Eastern Europe Market Value (US$ Mn) by Distribution Channel, 2024-2034

Figure 124: Eastern Europe Market Value (US$ Mn) by Country, 2024-2034

Figure 125: Eastern Europe Market Value (US$ Mn) Analysis by Country, 2019-2034

Figure 126: Eastern Europe Market Value Share (%) Analysis by Country, 2024-2034

Figure 127: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024-2034

Figure 128: Eastern Europe Market Value (US$ Mn) Analysis by Treatment, 2019-2034

Figure 129: Eastern Europe Market Value Share (%) Analysis by Treatment, 2024-2034

Figure 130: Eastern Europe Market Y-o-Y Growth (%) Projections by Treatment, 2024-2034

Figure 131: Eastern Europe Market Value (US$ Mn) Analysis by Type, 2019-2034

Figure 132: Eastern Europe Market Value Share (%) Analysis by Type, 2024-2034

Figure 133: Eastern Europe Market Y-o-Y Growth (%) Projections by Type, 2024-2034

Figure 134: Eastern Europe Market Value (US$ Mn) Analysis by Distribution Channel, 2019-2034

Figure 135: Eastern Europe Market Value Share (%) Analysis by Distribution Channel, 2024-2034

Figure 136: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024-2034

Figure 137: Eastern Europe Market Attractiveness by Treatment, 2024-2034

Figure 138: Eastern Europe Market Attractiveness by Type, 2024-2034

Figure 139: Eastern Europe Market Attractiveness by Distribution Channel, 2024-2034

Figure 140: Eastern Europe Market Attractiveness by Country, 2024-2034

Figure 141: Middle East & Africa Market Value (US$ Mn) by Treatment, 2024-2034

Figure 142: Middle East & Africa Market Value (US$ Mn) by Type, 2024-2034

Figure 143: Middle East & Africa Market Value (US$ Mn) by Distribution Channel, 2024-2034

Figure 144: Middle East & Africa Market Value (US$ Mn) by Country, 2024-2034

Figure 145: Middle East & Africa Market Value (US$ Mn) Analysis by Country, 2019-2034

Figure 146: Middle East & Africa Market Value Share (%) Analysis by Country, 2024-2034

Figure 147: Middle East & Africa Market Y-o-Y Growth (%) Projections by Country, 2024-2034

Figure 148: Middle East & Africa Market Value (US$ Mn) Analysis by Treatment, 2019-2034

Figure 149: Middle East & Africa Market Value Share (%) Analysis by Treatment, 2024-2034

Figure 150: Middle East & Africa Market Y-o-Y Growth (%) Projections by Treatment, 2024-2034

Figure 151: Middle East & Africa Market Value (US$ Mn) Analysis by Type, 2019-2034

Figure 152: Middle East & Africa Market Value Share (%) Analysis by Type, 2024-2034

Figure 153: Middle East & Africa Market Y-o-Y Growth (%) Projections by Type, 2024-2034

Figure 154: Middle East & Africa Market Value (US$ Mn) Analysis by Distribution Channel, 2019-2034

Figure 155: Middle East & Africa Market Value Share (%) Analysis by Distribution Channel, 2024-2034

Figure 156: Middle East & Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024-2034

Figure 157: Middle East & Africa Market Attractiveness by Treatment, 2024-2034

Figure 158: Middle East & Africa Market Attractiveness by Type, 2024-2034

Figure 159: Middle East & Africa Market Attractiveness by Distribution Channel, 2024-2034

Figure 160: Middle East & Africa Market Attractiveness by Country, 2024-2034

List of Tables

Table 01: Global Market Value (US$ Mn) Forecast by Region, 2019-2034

Table 02: Global Market Value (US$ Mn) Forecast by Treatment, 2019-2034

Table 03: Global Market Value (US$ Mn) Forecast by Type, 2019-2034

Table 04: Global Market Value (US$ Mn) Forecast by Distribution Channel, 2019-2034

Table 05: North America Market Value (US$ Mn) Forecast by Country, 2019-2034

Table 06: North America Market Value (US$ Mn) Forecast by Treatment, 2019-2034

Table 07: North America Market Value (US$ Mn) Forecast by Type, 2019-2034

Table 08: North America Market Value (US$ Mn) Forecast by Distribution Channel, 2019-2034

Table 09: Latin America Market Value (US$ Mn) Forecast by Country, 2019-2034

Table 10: Latin America Market Value (US$ Mn) Forecast by Treatment, 2019-2034

Table 11: Latin America Market Value (US$ Mn) Forecast by Type, 2019-2034

Table 12: Latin America Market Value (US$ Mn) Forecast by Distribution Channel, 2019-2034

Table 13: East Asia Market Value (US$ Mn) Forecast by Country, 2019-2034

Table 14: East Asia Market Value (US$ Mn) Forecast by Treatment, 2019-2034

Table 15: East Asia Market Value (US$ Mn) Forecast by Type, 2019-2034

Table 16: East Asia Market Value (US$ Mn) Forecast by Distribution Channel, 2019-2034

Table 17: South Asia & Pacific Market Value (US$ Mn) Forecast by Country, 2019-2034

Table 18: South Asia & Pacific Market Value (US$ Mn) Forecast by Treatment, 2019-2034

Table 19: South Asia & Pacific Market Value (US$ Mn) Forecast by Type, 2019-2034

Table 20: South Asia & Pacific Market Value (US$ Mn) Forecast by Distribution Channel, 2019-2034

Table 21: Western Europe Market Value (US$ Mn) Forecast by Country, 2019-2034

Table 22: Western Europe Market Value (US$ Mn) Forecast by Treatment, 2019-2034

Table 23: Western Europe Market Value (US$ Mn) Forecast by Type, 2019-2034

Table 24: Western Europe Market Value (US$ Mn) Forecast by Distribution Channel, 2019-2034

Table 25: Eastern Europe Market Value (US$ Mn) Forecast by Country, 2019-2034

Table 26: Eastern Europe Market Value (US$ Mn) Forecast by Treatment, 2019-2034

Table 27: Eastern Europe Market Value (US$ Mn) Forecast by Type, 2019-2034

Table 28: Eastern Europe Market Value (US$ Mn) Forecast by Distribution Channel, 2019-2034

Table 29: Middle East & Africa Market Value (US$ Mn) Forecast by Country, 2019-2034

Table 30: Middle East & Africa Market Value (US$ Mn) Forecast by Treatment, 2019-2034

Table 31: Middle East & Africa Market Value (US$ Mn) Forecast by Type, 2019-2034

Table 32: Middle East & Africa Market Value (US$ Mn) Forecast by Distribution Channel, 2019-2034